Effects of Exenatide on Hypothalamic Obesity.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 30 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 22 Feb 2016 According to ClinicalTrials.gov record, the primary endpoint has been amended.
- 22 Feb 2016 Planned End Date changed from 1 Feb 2014 to 1 Dec 2016, according to ClinicalTrials.gov record.